Literature DB >> 2758559

Effects of two pyridinalalkyliminerhodium(I) complexes in mice bearing MCa mammary carcinoma.

G Sava1, S Zorzet, S Pacor, G Mestroni, G Zassinovich.   

Abstract

The examination of the differential effects of two square-planar rhodium(I) complexes on primary tumor growth and on the formation of spontaneous and artificially (i.v. tumor injection) induced lung metastases of MCa mammary carcinoma suggests different mechanisms of action, depending on the chemical characteristics of the compound used. Of the two complexes used, cyclooctadiene(2-pyridinalmethylimine)Rh(I) chloride and cyclooctadiene(2-pyridinalisopropylimine)Rh(I) chloride, the former compound confirmed the antineoplastic action previously shown in the Lewis lung carcinoma model. The activity of this derivative on lung metastasis formation seems to be unrelated to a cytotoxic action for tumor cells localized in the lungs. More likely, it appears that modifications occurring at the primary tumor level, probably different from a tumor-cell-directed lethality, are responsible for the reduction of spontaneous lung metastasis formation observed in treated animals. The hyperplasia of the spleen induced in treated animals seems to suggest that this compound is endowed with properties typical for biological response modifiers.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2758559     DOI: 10.1007/BF00304762

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  8 in total

1.  A simplified method of evaluating dose-effect experiments.

Authors:  J T LITCHFIELD; F WILCOXON
Journal:  J Pharmacol Exp Ther       Date:  1949-06       Impact factor: 4.030

2.  Antitumor action of two rhodium and ruthenium complexes in comparison with cis-diamminedichloroplatinum(II).

Authors:  T Giraldi; G Sava; G Bertoli; G Mestroni; G Zassinovich
Journal:  Cancer Res       Date:  1977-08       Impact factor: 12.701

3.  Interaction of Rhodium(II) carboxylates with molecules of biologic importance.

Authors:  J L Bear; H B Gray; L Rainen; I M Chang; R Howard; G Serio; A P Kimball
Journal:  Cancer Chemother Rep       Date:  1975 May-Jun

4.  Antineoplastic activity of planar rhodium(I) complexes in mice bearing Lewis lung carcinoma and P388 leukemia.

Authors:  G Sava; S Zorzet; G Mestroni; G Zassinovich
Journal:  Anticancer Res       Date:  1985 May-Jun       Impact factor: 2.480

5.  Antitumor effects of rhodium(I), iridium(I) and ruthenium(II) complexes in comparison with cis-dichlorodiammino platinum(II) in mice bearing Lewis lung carcinoma.

Authors:  G Sava; T Giraldi; G Mestroni; G Zassinovich
Journal:  Chem Biol Interact       Date:  1983-07-01       Impact factor: 5.192

Review 6.  Chemical xenogenization of experimental tumors.

Authors:  P Puccetti; L Romani; M C Fioretti
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

7.  A study of the influence of various diagnostic and therapeutic procedures applied to a murine squamous carcinoma on its metastatic behaviour.

Authors:  L J Peters
Journal:  Br J Cancer       Date:  1975-09       Impact factor: 7.640

8.  Role of operative trauma: explosive metastases of similar size following amputation of the primary leg tumor.

Authors:  D Agostino; N Agostino
Journal:  Tumori       Date:  1979-10-31
  8 in total
  1 in total

Review 1.  Complexes of metals other than platinum as antitumour agents.

Authors:  P Köpf-Maier
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.